88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma Two head-to-head phase III trials demonstrated superior efficacy, including overall survival versus a daratumumab-based triplet in DREAMM-7 Blenrep, a first-in-class anti-BCMA ADC, could transform treatment ... 2026-08-19T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit SHANGHAI and HONG KONG , Aug. 19, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CARsgen Therapeutics Announces 2026 Interim Results SHANGHAI , Aug. 19, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2026 Interim Re ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited Yapan Bio Private Limited specializes in process development, characterization, and phase I and II GMP manufacturing services for vaccines and biologics. Piramal has held a stake in Yapan Bio since ... 2026-08-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles Adjusted net profit surges 203.3% as Gene-to-Protein generates two-thirds of GenScript Life Science Group revenue ... 2026-08-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence SINGAPORE , Aug. 18, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused ... 2026-08-18T Biotechnology Medical/Pharmaceuticals
Biosolutions could help Japan become a global bioeconomy powerhouse, new report finds A new report, The Value of Biosolutions: Growth and Prosperity to 2035 – Japan Edition , highlights how biosolutions could strengthen Japan's position as a global biomanufacturing hub and ... 2026-08-18T Agriculture Biotechnology Chemical Environmental Products & Services
Enginprime Medical Closes $12M Series A Financing Round exclusively led by Qiming Venture Partners; proceeds to fund China registration trial and overseas early-stage clinical development ... 2026-08-18T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths CAMBRIDGE, Mass. , Aug. 17, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI) , announced ... 2026-08-17T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors — ONC-783 is the first-and-only clinical-stage T-cell engager targeting a cancer-specific glycoform of CD24 (neoCD24) — ... 2026-08-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved